From the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Eluma has a registered holding activity and consists mainly of financial fixed assets. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.5m and a net result of €173,996. Equity has been growing by about 50% per year since 2023. Its solvency ranks better than 42% of 10,798 sector peers (NACE 70, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.
Financials · financial year 2025, abbreviated format
Annual accounts 2025
- Financial year ended
- 31-12-2025
- Filed on
- 10-07-2026
- Format
- abbreviated format
- Reference
- 2026-00278321
2023 to 2025, 3 financial years
The operating result for 2025 is 2% lower than in 2024 and the lowest since 2023. It is the second fall in a row.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Activities of head offices; management consultancy activities (NACE 70). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).
- 2024 Net result +591% on 2023. The accounts now follow the abbreviated format, last year the micro format.
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €281 | €0.002m | €0.003m | ▲ 3.7% |
| Other operating charges640/8 | €476 | €86 | €0.001m | ▲ 16× |
| Gross operating margin9900 | €0.3m | €0.3m | €0.3m | ▼ 1.1% |
| Operating profit (loss)9901 | €0.3m | €0.3m | €0.3m | ▼ 1.6% |
| Financial income75/76B | €206 | €1.0m | €0 | ▼ 100% |
| Recurring financial income75 | €206 | €1.0m | €0 | ▼ 100% |
| Financial charges65/66B | €0.08m | €0.06m | €0.05m | ▼ 12.4% |
| Recurring financial charges65 | €0.08m | €0.06m | €0.05m | ▼ 12.4% |
| Profit (loss) for the period before taxes9903 | €0.2m | €1.2m | €0.2m | ▼ 81.5% |
| Income taxes67/77 | €0.06m | €0.06m | €0.05m | ▼ 7.7% |
| Profit (loss) for the period9904 | €0.2m | €1.2m | €0.2m | ▼ 85.1% |
| Profit (loss) for the period to be appropriated9905 | €0.2m | €1.2m | €0.2m | ▼ 85.1% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €3.5m | €3.5m | €3.5m | ▼ 0.4% |
| Fixed assets21/28 | €3.4m | €3.4m | €3.4m | ▼ 0.1% |
| Tangible fixed assets22/27 | €0.009m | €0.01m | €0.007m | ▼ 25.5% |
| Other tangible fixed assets26 | €0.009m | €0.01m | €0.007m | ▼ 25.5% |
| Financial fixed assets28 | €3.4m | €3.4m | €3.4m | = |
| Current assets29/58 | €0.1m | €0.1m | €0.09m | ▼ 12.0% |
| Amounts receivable within one year40/41 | €0.04m | €0.08m | €0.06m | ▼ 26.2% |
| Trade receivables40 | €0.04m | €0.04m | €0.04m | = |
| Other amounts receivable41 | €8 | €0.04m | €0.02m | ▼ 49.8% |
| Current investments50/53 | €0.08m | €0 | - | - |
| Cash at bank and in hand54/58 | €0.03m | €0.03m | €0.03m | ▲ 30.9% |
| Deferred charges and accrued income490/1 | €413 | €0.002m | €0.001m | ▼ 18.1% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €3.5m | €3.5m | €3.5m | ▼ 0.4% |
| Equity10/15 | €0.2m | €1.3m | €1.5m | ▲ 13.0% |
| Contributions10/11 | €0.005m | €0.005m | €0.005m | = |
| Reserves13 | €0.2m | €1.3m | €1.5m | ▲ 13.0% |
| Distributable reserves133 | €0.2m | €1.3m | €1.5m | ▲ 13.0% |
| Amounts payable17/49 | €3.4m | €2.2m | €2.0m | ▼ 8.8% |
| Amounts payable after more than one year17 | €2.0m | €1.9m | €1.7m | ▼ 9.7% |
| Financial debts170/4 | €1.9m | €1.8m | €1.6m | ▼ 9.6% |
| Other amounts payable178/9 | €0.08m | €0.07m | €0.06m | ▼ 13.7% |
| Amounts payable within one year42/48 | €1.4m | €0.3m | €0.3m | ▼ 1.8% |
| Current portion of amounts payable after more than one year42 | €0.4m | €0.2m | €0.2m | ▲ 2.7% |
| Trade debts44 | €0.002m | €0.001m | €0.004m | ▲ 274% |
| Suppliers440/4 | €0.002m | €0.001m | €0.004m | ▲ 274% |
| Taxes, remuneration and social security45 | €0.08m | €0.07m | €0.07m | ▼ 5.6% |
| Taxes450/3 | €0.08m | €0.07m | €0.07m | ▼ 5.6% |
| Other amounts payable47/48 | €0.9m | €0.009m | €0.001m | ▼ 85.0% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €0.2m | €1.2m | €0.2m | ▼ 85.1% |
| + Depreciation and write-downs630 | €281 | €0.002m | €0.003m | ▲ 3.7% |
| Operating cash flow (approximation) | €0.2m | €1.2m | €0.2m | ▼ 84.9% |
| Investment in fixed assets (approximation) | - | -€0.004m | €0 | - |
| Change in cash | - | -€0.009m | €0.008m | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Comparable companies
These companies have the same main activity as Eluma: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €2.9m and €3.9m, founded between 2021 and 2022.
| Company | Founded | Total assets | Equity | Gross margin | Net result | FTE | Financial year |
|---|---|---|---|---|---|---|---|
| Eluma Ninove | 2022 | €3.5m | €1.5m | €0.3m | €0.2m | - | 2025 |
| TEC+ Sint-Niklaas | 2022 | €3.8m | €0.5m | €0.2m | €0.06m | - | 2025 |
| Enhace Buggenhout | 2022 | €3.8m | €0.5m | €0.3m | €0.3m | - | 2025 |
| HOLDING VANNESTE Wevelgem | 2022 | €3.4m | €0.6m | €0.3m | €0.3m | - | 2025 |
| Biosynex Pharma Benelux Sint-Joost-ten-Node | 2022 | €2.9m | €1.7m | €0.3m | -€0.7m | 7.2 | 2025 |
| GVDB Chaudfontaine | 2022 | €3.9m | €0.6m | €0.2m | €0.2m | - | 2025 |
| ISOVEST Deinze | 2021 | €3.8m | €1.4m | €0.2m | €1.0m | - | 2025 |
They were chosen from the 54,697 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.